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Purpose. To determine the expression and functional activity of pro-
ton-coupled oligopeptide transporters (POT) in retinal pigment epi-
thelial (RPE) cells.
Methods. RT-PCR was used to probe the presence of POT mRNA in
freshly isolated bovine RPE (BRPE) and human RPE (HRPE) cells,
a human RPE cell line (ARPE-19), and human and bovine neural
retina. [14C]GlySar uptake was used to characterize POT activity in
cultured ARPE-19 cells and freshly isolated BRPE cell sheet suspen-
sions.
Results. PHT1 mRNA was expressed in BRPE, HRPE, ARPE-19,
and bovine and human neural retina. In contrast, PEPT2 and PHT2
were expressed only in bovine and human retina, and PEPT1 could
not be detected. GlySar exhibited a linear uptake over 6 h at pH
values of 6.0 and 7.4, with greater uptake at pH 7.4 (p < 0.01). GlySar
uptake did not exhibit saturability (5–2000 M) and was unchanged
when studied in the presence of 1 mM L-histidine. In contrast, GlySar
uptake was significantly decreased when studied at 4°C or in the
presence of endocytic inhibitors at 37°C (p < 0.01). Studies in BRPE
cell sheet suspensions validated the results obtained in ARPE-19 cells
and strongly suggested the absence of POT on the apical and baso-
lateral membranes of RPE.
Conclusions. PHT1 mRNA is present in native bovine and human
RPE and a human RPE cell line. However, the data argue against
PHT1 being expressed on plasma membranes of RPE. Overall, Gly-
Sar appears to be taken up by RPE cells via a low-affinity, endocytic
process.
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INTRODUCTION
The retinal pigment epithelium (RPE) is a polarized ep-
ithelial monolayer that separates the retina from the under-
lying choroid and plays a key role in regulating the microen-
vironment surrounding the photoreceptor outer segments
(1,2). The RPE cells and their linking tight junctions form the
outer blood-retinal barrier that limits the diffusion of small
polar molecules between blood and retina. However, specific
carrier systems at the apical and basolateral membrane sur-
faces allow the RPE to selectively transport nutrients, me-
tabolites, and xenobiotics between the choroidal capillaries
and cells of the distal retina (1,3–6).
In mammals, the POT family currently consists of four
members (i.e., PEPT1, PEPT2, PHT1, PHT2) and is respon-
sible for the symport of small peptides/mimetics across bio-
logic membranes via an inwardly directed proton gradient
and negative membrane potential. PEPT1 was first cloned
from a rabbit intestinal cDNA library (7) and shown to be of
high capacity and low affinity for di- and tripeptides (8,9). It
is found primarily in the epithelia of intestine and, to a lesser
extent, in kidney (10). PEPT2 was subsequently cloned from
a human kidney cDNA library (11) and, in contrast to PEPT1,
was found to be of low capacity and high affinity (12). It is the
predominant POT in kidney. Together, PEPT1 and PEPT2
work in concert to efficiently absorb and conserve protein
digestive products arising in the intestine and kidney. More
recently, PEPT2 transcripts (13), protein (14,15), and func-
tional activity (16,17) have been reported in choroid plexus,
and, as a result, this transporter is believed to play a role in
neuropeptide homeostasis and the efflux of peptides/mimetics
from cerebrospinal fluid. PEPT2 mRNA is also expressed by
glial cells in the retina (13); however, its subcellular distribu-
tion and functional activity have not been investigated.
Two peptide/histidine transporters, PHT1 (18) and
PHT2 (19), were subsequently cloned from a rat brain cDNA
library. The transporters are distinct from PEPT1 and PEPT2
in that they transport the amino acid L-histidine as well as di-
and tripeptides. PHT1 and PHT2 share 49% amino acid iden-
tity, but homology to either rat PEPT1 or PEPT2 is less than
25%. Unfortunately, information on the tissue distribution,
cellular localization, and transport properties of these two
peptide/histidine transporters is limited. In this regard, it was
reported that PHT1 transcripts are abundantly expressed in
the brain and eye and that cloned PHT1 expressed in Xeno-
pus laevis oocytes transports L-histidine with high affinity (Km
of 17 M) (18). In contrast, PHT2 transcripts are abundant in
the lung, spleen, and thymus, have been detected faintly in the
brain, but have not been investigated in the eye (19). A pro-
ton-dependent uptake of L-histidine and histidyl-leucine was
observed when rat PHT2 protein was reconstituted into lipo-
somes, although the transport kinetics were not determined.
Thus, the physiologic role of specific POT family members in
the retina and RPE is unclear.
In the current study, we investigated which POT mem-
bers are present in RPE and retina and the potential func-
tional role of POT transporters in the RPE. Specifically, we
used RT-PCR to determine the presence of specific POT
mRNA in freshly isolated bovine RPE (BRPE) and human
RPE (HRPE) cells, a human RPE cell line (ARPE-19), as
well as bovine and human neural retina. The functional ac-
tivity of POT was characterized in ARPE-19 cells by uptake
assays with the model dipeptide GlySar and validated in
freshly isolated BRPE cell sheet suspensions.
MATERIALS AND METHODS
All animal procedures were approved by the University
of Michigan’s Unit for Laboratory Animal Medicine and ad-
hered to the “Principles of Laboratory Animal Care” (NIH
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publication 85-23, revised 1985). The isolation of human tis-
sues adhered to the tenets of the Declaration of Helsinki
promulgated in 1964 with informed consent being obtained.
Materials
[14C]Glycylsarcosine (GlySar; 106 mCi/mmol) was pur-
chased from Amersham Biotechnologies (Chicago, IL) and
[14C] D-mannitol (50 mCi/mmol) from Moravek Biochemicals
(Brea, CA). Dispase-II enzyme was purchased from Roche
Molecular Diagnostics (Indianapolis, IN), and Chee’s Essen-
tial Media (CEM) from Kemp Biotechnologies (Frederick,
MD). Primers for the RT-PCR analyses were synthesized by
Invitrogen Life Technologies (Carlsbad, CA). All other
chemicals were purchased from Sigma (St. Louis, MO).
Cell Cultures
ARPE-19 cells were obtained from ATCC (Rockville,
MD). Cells were grown in 75 cm2 cell culture flasks (BD
Biosciences, San Jose, CA) and were cultured in 1:1 DMEM/
F12 medium (Invitrogen, Carlsbad, CA) supplemented with
56 mM sodium bicarbonate, 2 mM L-glutamine, 15 mM
HEPES buffer, 10% fetal bovine serum (Invitrogen), and 1%
penicillin G (100 IU/ml)/streptomycin (100 mg/ml) solution
(Invitrogen). ARPE-19 cell monolayers were given fresh
complete medium every 3 to 4 days and were allowed to grow
until they reached approximately 80–90% confluency, as de-
termined by visualization with a light microscope. Subconflu-
ent cultures were passaged by dissociation in 0.05% trypsin
and 0.53 mM EDTA in Ca2+- and Mg2+-free Hanks buffered
saline solution and subsequently plated on to 24-well cell cul-
ture clusters (Costar) at a seeding density of 1.66 × 105 cells/
cm2. ARPE-19 cells were used for experiments between pas-
sages 21 and 30 and 7 to 8 days after initial seeding.
RT-PCR Analysis of POT mRNA Expression
RT-PCR was performed on ARPE-19 cells (grown in
standard propagation media or CEM), and freshly isolated
RPE and neural retina samples from bovine and human
sources. In brief, mRNA expression of PEPT1, PEPT2,
PHT1, and PHT2 was evaluated using the GeneAmp PCR
System® (Perkin Elmer, Boston, MA). Total RNA was iso-
lated from ARPE-19 cells and from freshly isolated human
and bovine samples with TRI Reagent® (Molecular Research
Center, Cincinnati, OH), according to the manufacturer’s
protocol. RNA was reverse-transcribed in a 20-l reaction
mixture using 200 U of SuperScript II® reverse transcriptase
and oligodT as a primer. cDNA amplification was performed
using specific 5 and 3 primers for the four oligopeptide
transporters. The primers (listed in Table I) were designed
using a multiple-sequence alignment program (Clustal
method with weighted residue weight table) and the known
DNA sequences from human, rat, mouse, and rabbit PEPT1
and PEPT2, and the known sequences from human and rat
PHT1 and PHT2. PCR was performed in a standard 50-l
reaction mixture containing 5 U of Taq DNA polymerase, 10
pmol each of the 5 and 3 primers for each POT, 10 mM
deoxytriphosphate nucleotide mixture, and 1.5 mM MgCl2.
PCR was also conducted on all cDNA sample preparations
using 10 pmol of the 5 and 3 primers for human -actin (i.e.,
internal control). The positive controls for each peptide trans-
porter were mouse small intestine (PEPT1), mouse kidney
(PEPT2), rat choroid plexus (PHT1), and rat lung (PHT2).
The negative controls, lacking sample cDNA, were run in an
identical manner. The PCR cycles consisted of denaturing at
94°C for 30 s, annealing of primers at 48°C for 30 s, primer
extension at 74°C for 1 min, and were repeated 40 times. The
amplified products were separated on a 1.2% agarose gel and
visualized with ethidium bromide.
Time Course of GlySar Uptake
GlySar uptake was measured in ARPE-19 cells using
transport buffer that contained 122 mM NaCl, 25 mM
NaHCO3, 1.2 mM MgSO4, 0.4 mM K2HPO4•3H2O, 1.4 mM
CaCl2, 10 mM glucose, 10 mM HEPES (pH 7.4) or 117 mM
NaCl, 5.4 mM KCl, 0.81 mM MgSO4, 25 mM NaHCO3, 0.78
mM NaH2PO4, 1.80 mM CaCl2, 5.55 mM glucose, and 15 mM
MES (pH 6.0). ARPE-19 cell monolayers were preincubated
with 1.0 ml of transport buffer (pH 7.4 or 6.0) for 10 min at
37°C and 5% CO2. The buffer was then removed, and the
time course study (up to 24 h) was initiated by the addition of
1.0 ml of the appropriate transport buffer containing 0.1 Ci
Table I. Primers for RT-PCR Analysis
PEPT1
Sense 5-CAC TGG CTG GAC TGG GCT AA-3
Antisense 5-GGA AGA GTT TTA TCG ATT TCC ACC TGC A-3
PEPT2
Sense 5-CCA TCA ATG CAG GGA GCT TGA TTT C-3
Antisense 5-ACC TGC ATC TGA TCC GGC TGG AA-3
PHT1
Sense 5-AGC CTC CTG ATG GCA GTG CCT T-3
Antisense 5-GCA TTT GCA AAT ACA CTG TCC AGT AAG-3
PHT2
Sense 5-TTC CAG ATG CAG TCC ACC TAT GT-3
Antisense 5-AGG CAG AAG AAG AAG ATG CCC ATG AT-3
-Actin
Sense 5-AAC CGC GAG AAG ATG ACC CAG ATC ATG TTT-3
Antisense 5-AGC AGC CGT GGC CAT CTC TTG CTC GAA GTC-3
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of [14C]GlySar (final concentration 10 M). To measure in-
tracellular accumulation of GlySar, the buffer was aspirated
at the end of the incubation period, and the cells were rapidly
washed three times with ice-cold buffer. The cells were then
solubilized with 1 ml of 1% SDS/0.2 M NaOH and transferred
to scintillation vials. EcoLite(+) (5 ml) (ICN, Irvine, CA) was
added to all the samples, which were counted on a dual-
channel liquid scintillation counter (Beckman LS 3801, Ful-
lerton, CA). The nonspecific component (i.e., nonspecific
binding) of GlySar uptake was determined by measuring the
amount of radiolabel uptake in the presence of an excess
amount (50 mM) of unlabeled substrate. This value was sub-
tracted from the overall uptake to calculate the specific up-
take for GlySar. As a control, similar studies were performed
with 0.1 Ci of [14C] D-mannitol (10 M), a nontransported
compound.
Concentration-Dependent Studies with GlySar
The potential for concentration-dependent uptake of
GlySar and mannitol was investigated in ARPE-19 monolay-
ers over a concentration range of 5–2000 M, at pH 6.0 and
7.4. The amount of radiolabeled GlySar and mannitol re-
mained constant at 0.1 Ci/well for all concentrations of sub-
strate studied. As described previously, cells were preincu-
bated with 1.0 ml of the respective uptake buffer for 10 min at
37°C and 5% CO2. The experiment was then initiated by
aspirating the buffer and adding transport buffer containing
the specific substrate concentration for 3 h (uptake for GlySar
and mannitol was linear for 6 h) at 37°C and 4°C. The intra-
cellular accumulation for GlySar and mannitol was deter-
mined in the absence and presence of excess (50 mM) unla-
beled substrate.
Effect of L-Histidine on GlySar Uptake
Transport buffer (pH 6.0 and 7.4) containing unlabeled 1
mM L-histidine and 10 M radiolabeled GlySar was added to
ARPE-19 monolayers grown on cell culture clusters and in-
cubated for 3 h at 37°C and 5% CO2. This experiment was
performed in order to determine if L-His could inhibit the
uptake of GlySar and, as a result, provide functional evidence
for the presence of either PHT1 or PHT2 on the apical mem-
brane of ARPE-19 cells.
Effect of Endocytic Inhibitors on GlySar Uptake
Stock solutions were prepared by dissolving cytochalasin
B (CCB) in ethanol and phenylarsine oxide (PAO) in dimeth-
yl sulfoxide at concentrations of 5 mM and 50 mM, respec-
tively. Appropriate volumes of each stock solution were
added to the corresponding uptake buffer (pH 6.0 and 7.4) to
achieve a final concentration of 10 M for each inhibitor.
ARPE-19 monolayers were preincubated for 30 min at 37°C
and 5% CO2 with transport buffer containing either CCB or
PAO. After the preincubation period, buffer was aspirated,
and the experiment initiated by the addition of transport
buffer containing radiolabeled and cold GlySar (i.e., 5–2000
M) and either endocytic inhibitor. The cells were then in-
cubated for 3 h at 37°C and 5% CO2. Each endocytic inhibitor
was studied at 10 M because this concentration can fully
inhibit endocytosis in other experimental cell culture systems
(20,21).
Time Course of GlySar Uptake in BRPE Cell
Sheet Suspensions
BRPE cell sheet suspensions were prepared, as described
previously (22). In brief, 10 adult bovine eyes were obtained
from a local slaughterhouse, and the eyes were enucleated
within 1 h of death and placed on ice. After removal of the
anterior segment, lens, vitreous, and neural retina, RPE cells
were dissociated from the eye by treatment with a 1% Dis-
pase-II solution at 37°C and 5% CO2 for 1 h. The enzyme
solution was then removed, and a HEPES-buffered Ringer
solution consisting of 135 mM NaCl, 5 mM KCl, 10 mM
HEPES, 10 mM glucose, 1.8 mM CaCl2 and 1.0 mM MgCl2
(titrated to pH 7.4 with NaOH) was added to the eye cups.
The RPE cell sheets were removed from Bruch’s membrane
by gentle pipetting with a Pasteur pipette. The BRPE cell
sheets were quickly washed and then aliquoted into pre-
weighed plastic microcentrifuge vials and centrifuged at 1000
rpm for 1 min. The resulting supernatant was removed, and
the wet tissue weight of the cell sheets was determined. To
each vial, 0.95 ml of pH 7.4 or pH 6.0 transport buffer (de-
scribed previously) was quickly added and incubated at 37°C
and 5% CO2 for 10 min. After the 10-min preincubation, 50
l of a concentrated transport buffer solution (200 M of
[14C]GlySar and unlabeled GlySar) was added to each vial to
initiate the uptake experiment and achieve a final GlySar
concentration of 10 M. The uptake experiment was termi-
nated by filtering the cell suspensions on a 0.2-m nylon filter
and washing the filter three times with ice-cold buffer. The
cells attached to the filter were then transferred to scintilla-
tion vials and solubilized with 1 ml of 1% SDS/0.2 M NaOH
for 1 h. Ecolite(+) was added, and the radioactivity associated
with the filter was determined by liquid scintillation counting.
The nonspecific binding of GlySar was determined in the
presence of 50 mM unlabeled substrate and was subtracted
from the overall uptake value. A correction was also made for
filter binding in which 1 ml of transport buffer (containing 10
M GlySar ± 50 mM unlabeled substrate) was filtered in the
absence of BRPE cells and then washed three times with
ice-cold buffer.
Protein Assay
The protein content of the solubilized ARPE-19 cell
monolayers was determined after each experiment by the
method of Bradford (23) using the DC Bio-Rad protein assay
kit, with bovine -globulin as the standard. Protein standards
and samples were run in triplicate.
Data Analysis
Data are reported as mean ± SE of four independent
experiments, with each experiment being run in triplicate.
The observed uptake of GlySar and mannitol were standard-
ized for total cellular protein (mg) in ARPE-19 cells and for
wet tissue weight (mg) of BRPE cell sheets. Statistical analy-
ses of two unpaired sample populations were performed using
analysis of variance (ANOVA), and the slopes of linear re-
gression analyses were compared using analysis of covariance
[SPSS for Windows, v9.0.1, Chicago, IL]. A probability of p 
0.05 was considered statistically significant.
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RESULTS
RT-PCR Analysis of POT Expression in the RPE
and Retina
Total RNA isolated from bovine and human RPE,
ARPE-19 cells, and bovine and human retina was examined
for PEPT1, PEPT2, PHT1, and PHT2 mRNA expression
(Fig. 1, Table II). The results demonstrate that PEPT1 tran-
scripts (Fig. 1A) were lacking in bovine and human samples
of RPE and neural retina. Although PEPT2 (Fig. 1A) and
PHT2 mRNA (Fig. 1B) were absent from bovine and human
RPE, both transporter transcripts were present in the neural
retina of both species. In contrast, PHT1 mRNA (Fig. 1B)
was expressed in bovine and human RPE, ARPE-19 cells, and
bovine and human neural retina. ARPE-19 cells grown in
CEM had the same PCR products as ARPE-19 cells grown in
standard media (gel not shown). -Actin internal controls
were run for all cDNA sample preparations (Fig. 1C), and
negative controls were included on the gels (not shown).
Functional Characterization of Dipeptide Uptake in
ARPE-19 Cells
GlySar, a hydrolysis- and peptidase-resistant model di-
peptide, was used to probe POT activity in ARPE-19 cells.
This dipeptide exhibited a linear cellular uptake for at least 6
h, with accumulation continuing for up to 24 h (Fig. 2A).
Intracellular accumulation was significantly greater at pH 7.4
than at pH 6.0 (p < 0.01; Fig. 2B), a finding opposite to that
expected for a proton-coupled oligopeptide transporter. In
contrast, mannitol uptake was pH-independent and signifi-
cantly less than that of GlySar at both pH values (p < 0.01;
Fig. 2B), indicating that the observed uptake of GlySar was
not mediated by a simple diffusional process. Time course
studies were also performed with 10 M GlySar (at pH 6.0
and 7.4) on ARPE-19 cells grown in CEM, a defined medium
that has been reported to support the polarized expression of
several transport proteins on the apical membrane in RPE
cell cultures (24). The results demonstrated the same pH de-
pendence and uptake profile for GlySar over 24 h, with values
statistically no different from cells grown in standard propa-
gation media (data not shown). Therefore, ARPE-19 cells,
cultured in standard propagation media, were used for all
functional activity studies.
There was no evidence for a saturable uptake of GlySar
or mannitol over the concentration range of 5–2000 M at
either pH 7.4 or 6.0 (Fig. 3). However, the cellular accumu-
lation of GlySar but not mannitol decreased by 78% (pH 7.4)
or 62% (pH 6.0) when the temperature was reduced to 4°C
(p < 0.01). Thus, GlySar appears to be actively transported at
37°C, which is dramatically limited at the lower temperature
of 4°C.
As a final test for functional PHT1 in the plasma mem-
brane, we measured the GlySar uptake in the presence of 1
mM L-histidine. Because PHT1 transports histidine with high
affinity (18), this concentration should be more than sufficient
to compete with GlySar for cellular uptake if PHT1 were
indeed present. The observed uptake values of GlySar, at pH
7.4 or 6.0, were not statistically different when studied in the
absence and presence of excess concentrations of L-histidine
(Fig. 4). This finding suggests that PHT1 is not present on the
apical membrane.
Mechanism for GlySar Uptake in ARPE-19 Cells
Because the uptake of GlySar in ARPE-19 cells was nei-
ther enhanced by low pH nor saturable, it is highly unlikely
that a POT is involved in the uptake process. Moreover,
PHT1 and PHT2 are not involved in GlySar uptake, given the
lack of inhibition by histidine. Yet, the temperature-
dependent uptake of GlySar and its significantly greater ac-
cumulation over mannitol suggest a specific mechanism for
uptake. Therefore, the potential role of endocytosis was ex-
amined using two different endocytic inhibitors, cytochalasin
B (CCB) (20) and phenylarsine oxide (PAO) (21). The addi-
tion of either 10 M CCB or 10 M PAO to the transport
buffer significantly reduced the uptake of GlySar at 37°C (at
pH 7.4 and 6.0) over the concentration range 5–2000 M (p <
0.01; Fig. 5). In fact, GlySar uptake at 4°C was essentially the
same as that obtained for GlySar at 37°C when in the pres-
Fig. 1. RT-PCR analysis of POT mRNA in RPE and neural retina (3 g total RNA). Samples were run on a 1.2% agarose
gel and visualized with ethidium bromide. A, Screening for PEPT1 and PEPT2 transcripts. B, Screening for PHT1 and
PHT2 transcripts. C, -Actin controls for ARPE-19, BRPE, HRPE, B. (bovine) retina and H. (human) retina cDNA
samples. Not shown are ARPE-19 cells grown in CEM, which exhibited the same products observed for ARPE-19 cells
grown in standard propagation media.
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ence of these two inhibitors. A pH-dependent uptake of Gly-
Sar was not observed in the presence of either CCB or PAO,
unlike the results obtained with GlySar in the absence of
endocytic inhibitors at 37°C (Figs. 2 and 3). Thus, it appears
that a low-affinity endocytic process is primarily responsible
for GlySar uptake in the RPE, one that is both pH- and
temperature-dependent (i.e., less endocytosis at lower pH
and temperature).
Time Course of GlySar Uptake in BRPE Cell
Sheet Suspensions
The above studies focused on the apical membrane of
ARPE-19 cells because previous studies have shown that oli-
gopeptide transporters (namely PEPT1 and PEPT2) are pre-
sent in apical membranes of epithelial cell lines (Caco-2 and
SKPT) (25) and choroid plexus epithelium (15). However, the
functional data from ARPE-19 cells argue against PHT1 be-
ing present in the apical membrane. As a result, we examined
the potential localization of PHT1 on basolateral membranes.
As shown in Fig. 6A, the time course profiles of GlySar up-
take in BRPE cell sheet suspensions (at pH 7.4 and 6.0) were
very similar to the profiles observed in ARPE-19 cells (Fig.
2A). In this regard, GlySar uptake appeared linear over the
time range studied, with a statistically greater amount of up-
take occurring at pH 7.4 than at pH 6.0 (p < 0.05; Fig. 6B).
Thus, in freshly isolated BRPE cells with an exposed baso-
lateral membrane, the same pH-dependent uptake of GlySar
to that found in ARPE-19 cells was observed. Again, this
result is contrary to what would be expected if a POT were
responsible for uptake on either the apical or basolateral
membrane of the cell.
DISCUSSION
Among the many diverse functions of the RPE is the
vectorial transport of nutrients and metabolites between the
choroidal circulation and the neural retina. This is accom-
plished by a wide array of specialized transporters located on
distinct apical and basolateral membranes of the cell. Previ-
ous studies have reported the presence of PEPT2 and PHT1
mRNA in retina (13) and eye (18), respectively. However, it
is unclear whether or not these same transporters or, perhaps,
other members of the POT family are expressed in RPE.
Moreover, their functional role has not been investigated in
this tissue. In theory, oligopeptide transporters could have a
profound impact on the trafficking of small peptides and pep-
tide-like drugs from systemic blood to retina or, conversely,
from retina to blood. For example, valganciclovir, which is
used for the treatment of cytomegalovirus retinitis, is also a
substrate for PEPT1 and PEPT2 (26). Thus, identifying which
POT members are present and active in RPE could provide a
new target to exploit for drug delivery purposes.
In the present study, we demonstrated that although
PEPT2, PHT1, and PHT2 transcripts are expressed in bovine
and human retina, PHT1 is the only known POT present in
the RPE of both species. However, results from GlySar up-
take studies in ARPE-19 cells and BRPE cell sheet suspen-
sions provide strong evidence that RPE cells do not express
any oligopeptide transporter, including PHT1, on either the
apical or basolateral membrane. If a POT were expressed on
the cell membrane, one would expect to see saturation in
GlySar uptake along with a significant increase in uptake at
pH 6.0 as compared to pH 7.4. Instead, there was no evidence
of capacity-limited (i.e., saturable) kinetics, and a greater up-
take was observed for GlySar at pH 7.4. The fact that GlySar
uptake was not inhibited by an excess concentration of L-
histidine provides additional evidence for PHT1 being absent
on the apical membrane of RPE. Although GlySar was not
specifically studied by Yamashita et al. (18), they reported
that L-histidine and carnosine were transported by Xenopus
oocytes expressing PHT1. Moreover, L-histidine uptake was
significantly inhibited by several dipeptides, including glycyl-
Table II. RT-PCR Screening for POT mRNA in the RPE and Retina





Bovine retina X X X
Human retina X X X
a X indicates the presence of a PCR product.
b ARPE-19 cells grown in Chee’s Essential Media (CEM).
Fig. 2. A, Time course for the apical uptake of GlySar (10 M) and mannitol (10 M) in ARPE-19 cell monolayers at
37°C. B, Effect of pH on the 3-h apical uptake of GlySar and mannitol. *p < 0.01, for pH 6.0 vs. pH 7.4. Data reported
as mean ± SE (n  4).
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glycine (GlyGly). Given these findings, it is reasonable to
assume that GlySar would also be transported by PHT1, if
present.
Several slice variants (A, A, and B) of human PHT1
were described by Botka et al. (27), and the nucleotide se-
quence data of a peptide/histidine transporter variant in brain
(i.e., human PTR4) was recently deposited in GenBank (ac-
cession number AY038999). Although our PHT1 primers
would have potential cross-reactivity with variants A and A
of PHT1, they would not cross-react with variant B. These
primers would also have potential cross-reactivity with PTR4.
Notwithstanding this uncertainty, the PHT1 variants (includ-
ing PTR4) are putative transporters at present because they
have not been cloned and/or tested for functional activity.
Our PEPT1 primers would not cross-react with the human
PEPT1 splice variant, PEPT1-RF (28). This variant is a pH-
sensing regulatory factor that modulates PEPT1 activity but,
when expressed alone, lacks transport function.
The decreased uptake of GlySar at lower pH or tempera-
ture values in ARPE-19 cells, along with its greater uptake
over mannitol, suggested the presence of a specific (i.e., non-
diffusional) transport process. In this regard, investigators
had reported an endocytic mechanism that was less efficient
at acidic pH for horseradish peroxidase uptake (29), and at
reduced temperature for liposomal uptake (30) into cells. To
test our hypothesis that endocytosis might be involved in the
uptake of GlySar in RPE, we chose two inhibitors with dif-
ferent mechanisms of action for study. CCB, an inhibitor of
microfilament-dependent processes (20), significantly de-
creased the uptake of GlySar by the ARPE-19 cell line. Like-
wise, PAO, an inhibitor of clathrin-dependent processes (21),
reduced the uptake of GlySar to values obtained in the ab-
sence of endocytic inhibitors at 4°C. Taken together, these
results suggest strongly that the majority (if not all) of Gly-
Sar’s intracellular accumulation in ARPE-19 cells occurs by a
low-affinity, nonsaturable endocytic process. It should be ap-
preciated that the rate of GlySar uptake by this endocytic
mechanism is much less than that expected by a POT-
mediated mechanism. At physiologic pH, GlySar (10 M)
was transported at about 0.2 pmol/mg/min in ARPE-19 cells
(this study) compared to about 8 pmol/mg/min when present
at 2 M in rat choroid plexus epithelial cells in primary cul-
ture (15). Corrected for concentration differences, GlySar up-
take is about 200× lower in RPE than in choroid plexus. It is
of interest to note this difference in transport considering that
both tissues are derived from neuroepithelium. Of course,
species differences (human vs. rat) and methodologic condi-
tions (cell line vs. primary cell culture) may also influence this
comparison.
ARPE-19 cells have been reported to have structural and
functional properties that are characteristic of RPE cells in
vivo (31). Additionally, ARPE-19 cells exhibit a polarized
distribution of cell surface markers and, thus, have been pro-
posed as a suitable in vitro model for HRPE cells (32). De-
spite these favorable characteristics, there is always some con-
cern that the observed lack of functional uptake for GlySar
via PHT1 may be limited to this cell line. Experiments were,
therefore, also performed in freshly isolated BRPE cell sheet
suspensions. Qualitatively, the results were very similar to
those obtained in ARPE-19 cells. These experiments also
demonstrated that PHT1 was not involved in GlySar uptake
across the basolateral membrane, a transport site that would
have been inaccessible in the ARPE-19 studies.
At this point, the role of PHT1 in the RPE is uncertain.
Although PHT1 mRNA is expressed in RPE, our functional
Fig. 3. Effect of concentration and temperature on the 3-h apical uptake of GlySar and mannitol in ARPE-19 cell
monolayers at (A) pH 7.4 and (B) pH 6.0. GlySar uptake was significantly reduced by lower temperature at pH 7.4 and
pH 6.0 (p < 0.01). No temperature differences were observed for mannitol uptake at either pH. Data reported as mean
± SE (n  4).
Fig. 4. Effect of 1 mM L-histidine on the 3-h apical uptake of GlySar
(10 M) in ARPE-19 cell monolayers at pH 7.4 and pH 6.0 (37°C).
No significant differences were observed at either pH. Data reported
as mean ± SE (n  4).
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studies with GlySar in ARPE-19 cell cultures and native bo-
vine RPE sheets do not support its presence at either the
apical or basolateral membrane. Given these two findings, we
speculate that PHT1 is located on the membrane of an intra-
cellular organelle such as a lysosome and is involved in the
intracellular trafficking of small peptides. Such a hypothesis is
supported by the lack of functional activity for peptide/
histidine transporters (in contrast to PEPT2) in the uptake of
GlySar in freshly isolated rat choroid plexus (16) and primary
cell cultures of rat choroid plexus epithelium (15). Additional
support is provided by the observed lysosomal localization of
rPHT2 protein in transfected HEK-293T and BHK cells (19).
Still, other studies have reported the existence of a low-
affinity dipeptide transporter in rat liver and kidney lysosom-
al membranes that appears to belong to the POT family
(33,34). These results suggest an extended role of oligopep-
tide transporters, where they not only transport small pep-
tides and peptidomimetic compounds from the extracellular
environment across the plasma membrane but may also be
involved in trafficking and transport within the cell.
The known cellular characteristics of RPE cells lend cre-
dence to the need for PHT1 in the intracellular milieu. RPE
cells are rich in smooth endoplasmic reticulum and lysosomes,
reflecting the high metabolic rate of this tissue (35). RPE cells
function in the internalization and subsequent degradation of
rod outer segment fragments, which are shed continuously
from the ends of photoreceptors (36). With the relatively
large amount of protein taken in by the RPE, and the corre-
sponding large amount of protein degradation that is occur-
ring, there may be a situation created that requires an oligo-
peptide transport system that can efficiently translocate the
end products of protein degradation from inside the lysosome
to the cytosol. This would help to prevent osmotically-
induced swelling and rupture of lysosomes.
In conclusion, this study is the first to demonstrate that
several proton-coupled oligopeptide transporters are present
in the RPE and neural retina. Although PEPT2, PHT1, and
PHT2 mRNA are expressed in bovine and human retina,
PHT1 is uniquely found in RPE. However, a POT-mediated
uptake of the dipeptide GlySar was conspicuously absent in
ARPE-19 cells and bovine RPE cell sheet suspensions. In-
stead, it appears that GlySar enters RPE cells by a low-
affinity, endocytic mechanism. Moreover, the lack of func-
tional activity at the apical and/or basolateral membrane of
RPE cells suggests an intracellular localization of PHT1, per-
haps in lysosomes. Based on the molecular and functional
results in ARPE-19 cells, this cell line seems to be a suitable
in vitro model for subsequent studies of PHT1 in human RPE.
Fig. 5. Effect of cytochalasin B (CCB; 10 M) and phenylarsine oxide (PAO; 10 M) on the 3-h apical uptake of GlySar
(5–2000 M) in ARPE-19 cell monolayers (37°C) at (A) pH 7.4 and (B) pH 6.0. GlySar uptake was significantly reduced
by endocytic inhibitors (CCB or PAO) at pH 7.4 and pH 6.0 (p < 0.01). Data reported as mean ± SE (n  4).
Fig. 6. A, Time course for the uptake of GlySar (10 M) in BRPE cell sheet suspensions (37°C) at pH 7.4 and pH 6.0.
B, Effect of pH on the 3-h uptake of GlySar. *p < 0.05 for pH 6.0 vs. pH 7.4. Data reported as mean ± SE (n  4).
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In particular, the preparation of lysosomal membrane vesicles
will allow one to test whether or not PHT1 is located intra-
cellularly and is responsible for exporting histidine, di- and
tripeptides, and peptidomimetic compounds from the highly
acidic environment of the lysosome to the more physiologic
pH of the cytosol.
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